Cite
HARVARD Citation
Gluz, O. et al. (n.d.). 1937 Clinical impact of risk classification by central/local grade or luminal-like subtype vs. Oncotype DX®: First prospective survival results from the WSG phase III planB trial. European journal of cancer. pp. S311-. [Online].